ZA847409B - Pharmaceutical compositions - Google Patents
Pharmaceutical compositionsInfo
- Publication number
- ZA847409B ZA847409B ZA847409A ZA847409A ZA847409B ZA 847409 B ZA847409 B ZA 847409B ZA 847409 A ZA847409 A ZA 847409A ZA 847409 A ZA847409 A ZA 847409A ZA 847409 B ZA847409 B ZA 847409B
- Authority
- ZA
- South Africa
- Prior art keywords
- pharmaceutical compositions
- pharmaceutical
- compositions
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/89—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to the ring nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
- C07F15/02—Iron compounds
- C07F15/025—Iron compounds without a metal-carbon linkage
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Hematology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB838325496A GB8325496D0 (en) | 1983-09-23 | 1983-09-23 | Pharmaceutical compositions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA847409B true ZA847409B (en) | 1986-05-28 |
Family
ID=10549201
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA847409A ZA847409B (en) | 1983-09-23 | 1984-09-20 | Pharmaceutical compositions |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US4587240A (OSRAM) |
| EP (1) | EP0138420B1 (OSRAM) |
| JP (2) | JPS6094966A (OSRAM) |
| CY (1) | CY1574A (OSRAM) |
| DE (1) | DE3480599D1 (OSRAM) |
| DK (1) | DK161703C (OSRAM) |
| GB (2) | GB8325496D0 (OSRAM) |
| GR (1) | GR80444B (OSRAM) |
| HK (1) | HK7091A (OSRAM) |
| SG (1) | SG93290G (OSRAM) |
| ZA (1) | ZA847409B (OSRAM) |
Families Citing this family (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8308054D0 (en) * | 1983-03-24 | 1983-05-05 | Hider R C | Pharmaceutical compositions |
| GB8308055D0 (en) * | 1983-03-24 | 1983-05-05 | Hider R C | Pharmaceutical compositions |
| US4912118A (en) * | 1983-09-23 | 1990-03-27 | National Research Development Corporation | Pharmaceutical compositions |
| USRE34313E (en) * | 1983-09-23 | 1993-07-13 | National Research Development Corporation | Pharmaceutical compositions |
| GB8325496D0 (en) * | 1983-09-23 | 1983-10-26 | Hider R C | Pharmaceutical compositions |
| GB8329043D0 (en) * | 1983-10-31 | 1983-11-30 | Hider R C | Pharmaceutical compositions |
| US5177068A (en) * | 1984-04-19 | 1993-01-05 | National Research Development Corporation | Pharmaceutical compositions |
| US5010191A (en) * | 1985-08-19 | 1991-04-23 | The Regents Of The University Of California | Imaging agents for in vivo magnetic resonance and scintigraphic imaging |
| MX9203808A (es) * | 1987-03-05 | 1992-07-01 | Liposome Co Inc | Formulaciones de alto contenido de medicamento: lipido, de agentes liposomicos-antineoplasticos. |
| CA1338702C (en) * | 1987-03-05 | 1996-11-12 | Lawrence D. Mayer | High drug:lipid formulations of liposomal- antineoplastic agents |
| US4908371A (en) * | 1987-11-10 | 1990-03-13 | Ciba-Geigy Corporation | Esterified hydroxy dihydropyridinones for treating diseases associated with trivalent metal ion overload |
| GB8910521D0 (en) * | 1989-05-08 | 1989-06-21 | Nat Res Dev | The stabilization of organic compounds |
| US5443813A (en) * | 1991-06-06 | 1995-08-22 | Associated Universities, Inc. | Loading and conjugating cavity biostructures |
| ES2230564T3 (es) | 1995-06-10 | 2005-05-01 | Vitra Pharmaceuticals Ltd. | Compuestos ferricos, composiciones, metodos de fabricacion de estos y sus utilizacioneds. |
| US5667933A (en) * | 1996-02-26 | 1997-09-16 | Polaroid Corporation | Image-recording element |
| GB9625638D0 (en) * | 1996-12-10 | 1997-01-29 | Cenes Ltd | Therapeutic antioxidants for alzheimer's diease |
| JP2002534468A (ja) | 1999-01-13 | 2002-10-15 | バイエル コーポレイション | ｐ３８キナーゼ阻害剤としてのω−カルボキシアリール置換ジフェニル尿素 |
| US8124630B2 (en) | 1999-01-13 | 2012-02-28 | Bayer Healthcare Llc | ω-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors |
| US7135196B2 (en) * | 2000-09-19 | 2006-11-14 | Vitra Pharmaceuticals Limited | Iron compositions |
| PT1478358E (pt) | 2002-02-11 | 2013-09-11 | Bayer Healthcare Llc | Tosilato de sorafenib para o tratamento de doenças caracterizadas por angiogénese anormal |
| GB0211500D0 (en) * | 2002-05-18 | 2002-06-26 | Vitra Pharmaceuticals Ltd | Method of forming iron hydroxypyrone compounds |
| US7557129B2 (en) | 2003-02-28 | 2009-07-07 | Bayer Healthcare Llc | Cyanopyridine derivatives useful in the treatment of cancer and other disorders |
| US7595073B2 (en) * | 2003-02-28 | 2009-09-29 | Kraft Foods Global Brands Llc | Use of siderophores and organic acids to retard lipid oxidation |
| PL1626714T3 (pl) | 2003-05-20 | 2007-12-31 | Bayer Healthcare Llc | Diarylowe pochodne mocznika do schorzeń, w których pośredniczy PDGFR |
| CN102816113B (zh) | 2003-07-23 | 2015-05-13 | 拜耳医药保健有限责任公司 | 用于治疗和预防疾病和疾病症状的氟代ω-羧芳基二苯基脲 |
| WO2008116301A1 (en) | 2007-03-28 | 2008-10-02 | Apotex Technologies Inc. | Fluorinated derivatives of deferiprone |
| BRPI0822206B8 (pt) | 2008-04-25 | 2021-05-25 | Apotex Tech Inc | formulação líquida para deferiprona com um sabor agradável. |
| ES2524342T3 (es) | 2009-07-03 | 2014-12-05 | Apotex Technologies Inc. | Derivados fluorados de 3-hidroxipiridin-4-unos |
| TWI426900B (zh) | 2010-03-23 | 2014-02-21 | Vifor Int Ag | 用於治療及預防鐵缺乏症狀及缺鐵性貧血之Ｆｅ（ＩＩＩ）複合化合物 |
| TWI510496B (zh) | 2011-03-29 | 2015-12-01 | Vifor Int Ag | 用於治療及預防鐵缺乏症狀及缺鐵性貧血之Ｆｅ（ＩＩＩ）錯化合物 |
| EP2714030B1 (de) | 2011-05-31 | 2015-08-12 | Vifor (International) AG | Fe(iii)-2,4-dioxo-1-carbonyl-komplexverbindungen zur verwendung bei der behandlung und der prophylaxe von eisenmangelerscheinungen und eisenmangelanämien |
| CA2864577A1 (en) * | 2012-04-05 | 2013-10-05 | Vifor (International) Ag | Fe(iii) complex compounds for the treatment and prophylaxis of iron deficiency symptoms and iron deficiency anemias |
| MX2015007974A (es) | 2012-12-21 | 2016-03-09 | Vifor Int Ag | Compuestos de complejos de fe (iii) para el tratamiento y la profilaxis de los sintomas de la deficiencia de hierro y las anemias por deficiencia de hierro. |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2748142A (en) * | 1956-05-29 | - process of production | ||
| GB778871A (en) * | 1955-02-14 | 1957-07-10 | Sadolin & Holmblad As | Pyridinediol oxides and acetates thereof and their preparation |
| GB791719A (en) * | 1955-02-15 | 1958-03-12 | Sadolin & Holmblad As | Improvements in or relating to the production of cyclic hydroxamic acids of the pyridine series |
| GB790584A (en) * | 1955-02-15 | 1958-02-12 | Sadolin & Holmblad As | Improvements in or relating to the production of cyclic hydroxamic acids of the pyridine series |
| FR3691M (fr) * | 1963-05-06 | 1965-11-15 | Olin Mathieson | Nouvelle composition pharmaceutique utile en tant que fongicide. |
| NL156397B (nl) * | 1968-08-31 | 1978-04-17 | Hoechst Ag | Werkwijze voor het bereiden van preparaten tegen schimmelaandoeningen, gevormde preparaten, alsmede werkwijze voor het bereiden van daarvoor geschikte actieve stoffen. |
| US3968118A (en) * | 1968-08-31 | 1976-07-06 | Hoechst Aktiengesellschaft | Process for the manufacture of 1-hydroxy-2-pyridones |
| US3705943A (en) * | 1969-07-18 | 1972-12-12 | Olin Corp | Dialkyltin salts of substituted pyridine-1-oxides as fungicides and bactericides |
| EG10850A (en) * | 1972-03-25 | 1976-06-30 | Hoechst Ag | Process for the preparation of 1-hydroxy-pyridones |
| DE2705562A1 (de) * | 1977-02-10 | 1978-08-17 | Basf Ag | Verfahren zur herstellung von pyridonen |
| US4358455A (en) * | 1980-12-23 | 1982-11-09 | Merck & Co., Inc. | Aralkylamindethanol heterocyclic compounds |
| JPS5832812A (ja) * | 1981-08-21 | 1983-02-25 | Lion Corp | 毛髪化粧料 |
| GB2118176B (en) * | 1982-03-24 | 1985-12-04 | Nat Res Dev | Pharmaceutical compositions |
| GB2117766B (en) * | 1982-03-24 | 1985-08-29 | Nat Res Dev | Pharmaceutical compositions |
| DE3278014D1 (en) * | 1982-10-01 | 1988-02-25 | Merck & Co Inc | Aralkylaminoethanol heterocyclic compounds |
| GB8325496D0 (en) * | 1983-09-23 | 1983-10-26 | Hider R C | Pharmaceutical compositions |
| US4698431A (en) * | 1985-11-12 | 1987-10-06 | The United States Of America As Represented By The United States Department Of Energy | Hydroxypyridonate chelating agents |
-
1983
- 1983-09-23 GB GB838325496A patent/GB8325496D0/en active Pending
-
1984
- 1984-09-18 US US06/651,772 patent/US4587240A/en not_active Ceased
- 1984-09-20 EP EP84306437A patent/EP0138420B1/en not_active Expired
- 1984-09-20 ZA ZA847409A patent/ZA847409B/xx unknown
- 1984-09-20 DE DE8484306437T patent/DE3480599D1/de not_active Expired - Lifetime
- 1984-09-20 GB GB08423800A patent/GB2146990B/en not_active Expired
- 1984-09-21 DK DK453584A patent/DK161703C/da not_active IP Right Cessation
- 1984-09-21 GR GR80444A patent/GR80444B/el unknown
- 1984-09-25 JP JP59201407A patent/JPS6094966A/ja active Granted
-
1990
- 1990-11-19 SG SG932/90A patent/SG93290G/en unknown
-
1991
- 1991-01-24 HK HK70/91A patent/HK7091A/en unknown
- 1991-12-20 CY CY1574A patent/CY1574A/xx unknown
-
1992
- 1992-09-17 JP JP4248272A patent/JPH0811729B2/ja not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| CY1574A (en) | 1991-12-20 |
| DK453584A (da) | 1985-03-24 |
| GB2146990A (en) | 1985-05-01 |
| GB8325496D0 (en) | 1983-10-26 |
| JPS6094966A (ja) | 1985-05-28 |
| SG93290G (en) | 1991-01-18 |
| HK7091A (en) | 1991-02-01 |
| DE3480599D1 (de) | 1990-01-04 |
| EP0138420A2 (en) | 1985-04-24 |
| DK453584D0 (da) | 1984-09-21 |
| GR80444B (en) | 1985-01-23 |
| JPH05246992A (ja) | 1993-09-24 |
| GB8423800D0 (en) | 1984-10-24 |
| JPH0566385B2 (OSRAM) | 1993-09-21 |
| DK161703B (da) | 1991-08-05 |
| US4587240A (en) | 1986-05-06 |
| EP0138420A3 (en) | 1987-05-20 |
| DK161703C (da) | 1992-01-20 |
| GB2146990B (en) | 1987-05-20 |
| EP0138420B1 (en) | 1989-11-29 |
| JPH0811729B2 (ja) | 1996-02-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB2136807B (en) | Pharmaceutical compositions | |
| GB8423339D0 (en) | Pharmaceutical compositions | |
| GB8403668D0 (en) | Pharmaceutical compositions | |
| DE3467703D1 (en) | Pharmaceutical compositions | |
| GB8313217D0 (en) | Pharmaceutical compositions | |
| GB8415975D0 (en) | Pharmaceutical compositions | |
| GR80445B (en) | Pharmaceutical compositions | |
| GB8308126D0 (en) | Pharmaceutical compositions | |
| ZA847409B (en) | Pharmaceutical compositions | |
| CY1678A (en) | Pharmaceutical compositions | |
| GB2136806B (en) | Pharmaceutical compositions | |
| GB8414458D0 (en) | Pharmaceutical compositions | |
| CY1503A (en) | Pharmaceutical compositions | |
| GB8412569D0 (en) | Pharmaceutical compositions | |
| GB8323553D0 (en) | Pharmaceutical compositions | |
| GB8406132D0 (en) | Pharmaceutical compositions | |
| EP0136006A3 (en) | Pharmaceutical compositions | |
| GB8300767D0 (en) | Pharmaceutical compositions | |
| GB8416358D0 (en) | Pharmaceutical compositions | |
| GB8305697D0 (en) | Pharmaceutical compositions | |
| GB8425250D0 (en) | Pharmaceutical compositions | |
| GB2150435B (en) | Pharmaceutical compositions | |
| GB8331776D0 (en) | Pharmaceutical compositions | |
| IE830600L (en) | Pharmaceutical compositions | |
| GB8331425D0 (en) | Pharmaceutical compositions |